NCT00032695View on ClinicalTrials.gov

Treatment of AIDS Vacuolar Myelopathy With Methionine

PHASE3CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

Not specified

Conditions
MyelopathyAIDS-MyelopathyAIDS Vacuolar Myelopathy
Interventions
DRUG

methionine

Trial Locations (1)

10003

Beth Israel Medical Center, New York

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00032695 - Treatment of AIDS Vacuolar Myelopathy With Methionine | Biotech Hunter | Biotech Hunter